| 1.09 Data as of 3:59pm ET |  +0.0699 / +6.85%Today’s Change | 0.91 Today|||52-Week Range 1.70 | -8.41% Year-to-Date |
| Previous close | 1.02 |
| Today’s open | 1.03 |
| Day’s range | 1.03 - 1.09 |
| Volume | 8,700 |
| Average volume (3 months) | 29,202 |
| Market cap | $47.1M |
| Dividend yield | -- |
| Earnings growth (last year) | +8.00% |
| Earnings growth (this year) | -5.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -8.38% |
| P/E ratio | NM |
| Price/Sales | 3.22 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| DRADDigirad Corp | 0.00 | 0.00% |
| BSDMBSD Medical Corp | -0.10 | -7.46% |
| GTHPGuided Therapeutics ... | +0.01 | +0.66% |
| AXGNAxoGen Inc | 0.00 | 0.00% |
| Next reporting date | August 14, 2013 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $15.3M |
| Annual profit (last year) | -$10.6M |
| Net profit margin | -69.06% |
Sector Health Technology |
Industry Medical Specialties |
Chairman Lewis C. Pell |
Chief Executive Officer Howard I. Zauberman |
Corporate headquarters Orangeburg, New York |
.
